查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1596742

干细胞检测市场：按产品、检测和应用分类 - 2025-2030 年全球预测

Stem Cell Assays Market by Product (Instruments, Reagents & Kits), Assay (Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays), Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

干细胞检测市场2023年估值为27.5亿美元，预计到2024年将达到33.7亿美元，复合年增长率为22.65%，预计到2030年将达到115.2亿美元。

干细胞检测是生物技术和医学研究的重要工具，主要用于评估干细胞的增殖、分化和遗传稳定性等特性。人们对干细胞在再生医学、药物发现和发育生物学中的潜力的日益了解凸显了它们的需求。干细胞可应用于药物开发、毒性测试、癌症研究和再生医学，最终用途主要是製药公司、生技公司和学术研究机构。主要成长动力包括个人化医疗需求的增加、自动化程度的提高以及人工智慧技术的快速整合以实现高通量筛检过程。最近的技术进步和 3D 细胞培养技术的出现降低了检测成本，提供了利润丰厚的机会。然而，该市场也面临重大障碍，例如严格的监管环境、干细胞研究的伦理问题以及与先进检测技术相关的高成本，可能阻碍广泛采用。为了发展您的业务，您应该专注于应对这些挑战的创新，例如开发具有成本效益的检测解决方案和提供药物反应高预测准确性的人性化模型。此外，协作研究和开发工作可以帮助自动化和提高检测灵敏度。在持续的科学突破和不断变化的监管政策的推动下，市场竞争激烈且快速发展。为了保持领先地位，我们必须关注新兴趋势，例如机器学习和干细胞检测的整合以增强预测分析。公司必须投资强大的研发开发平臺，利用跨产业协作，并维持适应性策略以应对技术进步和监管变化。这些努力将有助于充分利用成长潜力，并在这个快速成长的行业中建立竞争优势。

主要市场统计
基准年[2023] 27.5亿美元
预测年份 [2024] 33.7亿美元
预测年份 [2030] 115.2亿美元
复合年增长率（%） 22.65%

市场动态：快速发展的干细胞检测市场的关键市场洞察

供需的动态交互作用正在改变干细胞检测市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 人们越来越认识到干细胞的治疗益处
    • 全球干细胞研究支出增加
    • 药物发现中对细胞分析的需求不断增长
  • 市场限制因素
    • 胚胎干细胞研究的挑战
  • 市场机会
    • 支持干细胞临床研究的资金和津贴的可用性
    • 新型干细胞分析系统的开发与行销
  • 市场挑战
    • 新兴国家缺乏干细胞研究基础设施
    • 缺乏训练有素、技术熟练的专业人员

波特五力：驾驭干细胞检测市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解干细胞检测市场的外部影响

外部宏观环境因素在塑造干细胞检测市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解干细胞侦测市场的竞争格局

干细胞检测市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质干细胞检测市场供应商绩效评估

FPNV定位矩阵是评估干细胞检测市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了干细胞检测市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，干细胞检测市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们越来越认识到干细胞的治疗益处
      • 世界各地对干细胞研究的资助增加
      • 药物发现中对细胞分析的需求增加
    • 抑制因素
      • 胚胎干细胞研究的问题
    • 机会
      • 支持干细胞临床研究的资金和津贴的可用性
      • 新型干细胞分析系统的开发与发布
    • 任务
      • 新兴国家缺乏干细胞研究基础设施
      • 缺乏训练有素、技术熟练的专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章干细胞检测市场：副产品

  • 装置
  • 试剂和套件

第七章干细胞检测市场分析

  • 细胞凋亡检测
  • 细胞鑑定试验
  • 分离和精製分析
  • 活力或细胞毒性测试

第八章干细胞检测市场：依应用分类

  • 临床调查
  • 药物发现与开发
  • 再生医学和治疗

第九章美洲干细胞检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太干细胞检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的干细胞检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Astellas Pharma Inc.
  • Bio-Rad Laboratories, Inc.
  • BioTime, Inc.
  • Biovault Family Ltd.
  • Caladrius Biosciences, Inc.
  • Celgene Corporation
  • Cell Biolabs, Inc.
  • HemoGenix, Inc.
  • Mesoblast Ltd
  • Miltenyi Biotec GmbH
  • Opexa Therapeutics, Inc.
  • PerkinElmer, Inc.
  • Pluristem Therapeutics Inc
  • Precious Cells International Ltd
  • ReNeuron Group PLC
Product Code: MRR-0D217D5AF84D

The Stem Cell Assays Market was valued at USD 2.75 billion in 2023, expected to reach USD 3.37 billion in 2024, and is projected to grow at a CAGR of 22.65%, to USD 11.52 billion by 2030.

Stem cell assays are pivotal tools in biotechnology and medical research, primarily used to assess the properties of stem cells, including their proliferation, differentiation, and genetic stability. The increased understanding of these cells' potential in regenerative medicine, drug discovery, and developmental biology underscores their necessity. They find applications across drug development, toxicity testing, cancer research, and regenerative medicine, with end-use predominantly in pharmaceutical companies, biotechnology firms, and academic research institutes. Key growth drivers include the escalating demand for personalized medicine, ongoing advancements in automation, and the rapid integration of AI technologies enabling high-throughput screening processes. Recent technological improvements reducing assay costs and the emergence of 3D cell culture techniques offer lucrative opportunities. However, the market also faces significant hurdles, such as the stringent regulatory landscape, ethical concerns surrounding stem cell research, and the high cost associated with advanced assay technologies, potentially hindering widespread adoption. For business growth, organizations should focus on innovations addressing these challenges, such as developing cost-effective assay solutions or exploring more humanized models that offer high predictive accuracy for drug responses. Engaging in collaborative research and development initiatives can also spur advancements in automating and improving assay sensitivity. The nature of the market is highly competitive and rapidly evolving, driven by continuous scientific breakthroughs and evolving regulatory policies. Staying ahead necessitates a keen focus on emerging trends such as the integration of machine learning with stem cell assays to enhance predictive analytics. Firms must invest in robust R&D pipelines, leverage cross-industry collaborations, and maintain adaptive strategies to keep pace with technological advancements and regulatory changes. These endeavors will help harness potential growth and carve a competitive edge in this burgeoning field.

KEY MARKET STATISTICS
Base Year [2023] USD 2.75 billion
Estimated Year [2024] USD 3.37 billion
Forecast Year [2030] USD 11.52 billion
CAGR (%) 22.65%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Stem Cell Assays Market

The Stem Cell Assays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness about therapeutic potency of stem cells
    • Rising funding for stem cell research globally
    • Growing demand for cell-based assays in drug discovery
  • Market Restraints
    • Issues in embryonic stem cell research
  • Market Opportunities
    • Availability of funding and grants to support the clinical research on stem cells
    • Development and launch of new stem cell analysis systems
  • Market Challenges
    • Lack of infrastructure for stem cell research in emerging economies
    • Dearth of trained and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Stem Cell Assays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Stem Cell Assays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Stem Cell Assays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Stem Cell Assays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Stem Cell Assays Market

A detailed market share analysis in the Stem Cell Assays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Stem Cell Assays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Stem Cell Assays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Stem Cell Assays Market

A strategic analysis of the Stem Cell Assays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Stem Cell Assays Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Bio-Rad Laboratories, Inc., BioTime, Inc., Biovault Family Ltd., Caladrius Biosciences, Inc., Celgene Corporation, Cell Biolabs, Inc., HemoGenix, Inc., Mesoblast Ltd, Miltenyi Biotec GmbH, Opexa Therapeutics, Inc., PerkinElmer, Inc., Pluristem Therapeutics Inc, Precious Cells International Ltd, and ReNeuron Group PLC.

Market Segmentation & Coverage

This research report categorizes the Stem Cell Assays Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Reagents & Kits.
  • Based on Assay, market is studied across Apoptosis Assays, Cell Identification Assays, Isolation & Purification Assays, and Viability or Cytotoxicity Assays.
  • Based on Application, market is studied across Clinical Research, Drug Discovery & Development, and Regenerative Medicine & Therapy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness about therapeutic potency of stem cells
      • 5.1.1.2. Rising funding for stem cell research globally
      • 5.1.1.3. Growing demand for cell-based assays in drug discovery
    • 5.1.2. Restraints
      • 5.1.2.1. Issues in embryonic stem cell research
    • 5.1.3. Opportunities
      • 5.1.3.1. Availability of funding and grants to support the clinical research on stem cells
      • 5.1.3.2. Development and launch of new stem cell analysis systems
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of infrastructure for stem cell research in emerging economies
      • 5.1.4.2. Dearth of trained and skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Stem Cell Assays Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits

7. Stem Cell Assays Market, by Assay

  • 7.1. Introduction
  • 7.2. Apoptosis Assays
  • 7.3. Cell Identification Assays
  • 7.4. Isolation & Purification Assays
  • 7.5. Viability or Cytotoxicity Assays

8. Stem Cell Assays Market, by Application

  • 8.1. Introduction
  • 8.2. Clinical Research
  • 8.3. Drug Discovery & Development
  • 8.4. Regenerative Medicine & Therapy

9. Americas Stem Cell Assays Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Stem Cell Assays Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Stem Cell Assays Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Astellas Pharma Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. BioTime, Inc.
  • 4. Biovault Family Ltd.
  • 5. Caladrius Biosciences, Inc.
  • 6. Celgene Corporation
  • 7. Cell Biolabs, Inc.
  • 8. HemoGenix, Inc.
  • 9. Mesoblast Ltd
  • 10. Miltenyi Biotec GmbH
  • 11. Opexa Therapeutics, Inc.
  • 12. PerkinElmer, Inc.
  • 13. Pluristem Therapeutics Inc
  • 14. Precious Cells International Ltd
  • 15. ReNeuron Group PLC

LIST OF FIGURES

  • FIGURE 1. STEM CELL ASSAYS MARKET RESEARCH PROCESS
  • FIGURE 2. STEM CELL ASSAYS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL STEM CELL ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. STEM CELL ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. STEM CELL ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. STEM CELL ASSAYS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL STEM CELL ASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. STEM CELL ASSAYS MARKET DYNAMICS
  • TABLE 7. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APOPTOSIS ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY CELL IDENTIFICATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY ISOLATION & PURIFICATION ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY VIABILITY OR CYTOTOXICITY ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL STEM CELL ASSAYS MARKET SIZE, BY REGENERATIVE MEDICINE & THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES STEM CELL ASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA STEM CELL ASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY ASSAY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM STEM CELL ASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. STEM CELL ASSAYS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. STEM CELL ASSAYS MARKET, FPNV POSITIONING MATRIX, 2023